Your browser doesn't support javascript.
loading
Correction to 'Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer'.
Wiegmans, Adrian P; Ward, Ambber; Ivanova, Ekaterina; Duijf, Pascal H G; Adams, Mark N; Najib, Idris Mohd; Van Oosterhout, Romy; Sadowski, Martin C; Kelly, Greg; Morrical, Scott W; O'Byrne, Ken; Lee, Jason S; Richard, Derek J.
Affiliation
  • Wiegmans AP; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Ward A; School of Medicine, University of Queensland, Herston, QLD, 4006, Australia.
  • Ivanova E; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Duijf PHG; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Adams MN; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Najib IM; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Van Oosterhout R; Epigenetics and Diseases Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.
  • Sadowski MC; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Kelly G; School of Medicine, University of Queensland, Herston, QLD, 4006, Australia.
  • Morrical SW; Department of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
  • O'Byrne K; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
  • Lee JS; School of Medicine, University of Queensland, Herston, QLD, 4006, Australia.
  • Richard DJ; Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.
NAR Cancer ; 3(3): zcab041, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34570837
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NAR Cancer Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NAR Cancer Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Reino Unido